[go: up one dir, main page]

FR2901479B1 - Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant - Google Patents

Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant

Info

Publication number
FR2901479B1
FR2901479B1 FR0604671A FR0604671A FR2901479B1 FR 2901479 B1 FR2901479 B1 FR 2901479B1 FR 0604671 A FR0604671 A FR 0604671A FR 0604671 A FR0604671 A FR 0604671A FR 2901479 B1 FR2901479 B1 FR 2901479B1
Authority
FR
France
Prior art keywords
calmodulin
immune response
response against
living organism
modified peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0604671A
Other languages
English (en)
Other versions
FR2901479A1 (fr
Inventor
Halina Zofia Malina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0604671A priority Critical patent/FR2901479B1/fr
Publication of FR2901479A1 publication Critical patent/FR2901479A1/fr
Application granted granted Critical
Publication of FR2901479B1 publication Critical patent/FR2901479B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0604671A 2006-05-24 2006-05-24 Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant Expired - Fee Related FR2901479B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0604671A FR2901479B1 (fr) 2006-05-24 2006-05-24 Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604671A FR2901479B1 (fr) 2006-05-24 2006-05-24 Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant

Publications (2)

Publication Number Publication Date
FR2901479A1 FR2901479A1 (fr) 2007-11-30
FR2901479B1 true FR2901479B1 (fr) 2009-09-04

Family

ID=38093362

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0604671A Expired - Fee Related FR2901479B1 (fr) 2006-05-24 2006-05-24 Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant

Country Status (1)

Country Link
FR (1) FR2901479B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2922769A1 (fr) * 2007-10-31 2009-05-01 Halina Malina Modification des sequences intrinsequement desordonnees pour la preparation de vaccins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791263B1 (fr) * 1999-03-26 2001-04-27 Halina Zofia Malina Preparations des medicaments bases sur une reponse immunitaire contre l'accumulation de proteines modifiees par l'acide xanthurenique

Also Published As

Publication number Publication date
FR2901479A1 (fr) 2007-11-30

Similar Documents

Publication Publication Date Title
EP1877090A4 (fr) Proteine de fusion trimere immunoglobulinique ox-40 et procedes d'utilisation
WO2007073478A8 (fr) Carte genetique du gene humain associe a la maladie de crohn
EP2077459A4 (fr) Corps d'affichage et article etiquete
IL238798A0 (en) Cytotoxic conjugate specific for ca6 antigen and methods for its use
IL177847A0 (en) Use of lipid conjugates in the treatment of disease
EP1976782A4 (fr) Systemes et procedes de deviation d'objets
PL2532679T3 (pl) Ludzkie przeciwciała przeciwko IL13 i zastosowania terapeutyczne
HK1114173A1 (en) Methods and compositions for the detection of biological molecules using a two particle complex
HRP20140271T1 (hr) Humana antitijela protiv bjesnoä†e i njihova uporaba
DE602004025038D1 (de) Artikel zum auffangen von körperexsudaten
IL199045A0 (en) Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
EP1921985A4 (fr) Systeme d'introduction de capteur de substance a analyser et procedes d'utilisation associes
PL1945673T3 (pl) Ukierunkowywanie i śledzenie antygenów w żywych komórkach
EP2069487A4 (fr) Detergents zwitterioniques pour le stockage et l'utilisation d'adn polymerases
IL193473A0 (en) Amide derivatives and their application for the treatment of g protein related diseases
EP1963853A4 (fr) Modules d'essais a reactifs d'essais et leurs procedes de preparation et d'emploi
SI1853631T1 (sl) Fuzijski konstrukti, ki zajemajo regijo FC in se vežejo na fosfatidilserine, ter njihova terapevtska uporaba
EP1972251A4 (fr) Contenant de type capsule et procédé d'administration l'utilisant
EP2064550A4 (fr) Compositions associees a prrg4 et procedes d'utilisation de celles-ci dans des procedes de diagnostic de tumeur
IL191064A0 (en) Real time nucleic acid detection in vivo using protein complementation
ZA200907326B (en) Microemulsions and their use for improving the biological efficacy of pesticides
IL225695A0 (en) A pharmaceutical preparation containing belaslazide or belaslazide sodium for use in the treatment of gastrointestinal diseases
IL212214A0 (en) Use of lipid conjugates in the treatment of disease
EP2117450A4 (fr) Implants d'apophyses rachidiens et procédés
FR2901479B1 (fr) Reponse immunitaire contre les peptides modifies de facon covalente qui modifient d'interactions de phosphatidylinositol phosphates et calmoduline dans un organisme vivant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20180131